Cardiovascular Risk in Patients With IBD
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS Policlinico S. Donato
About this trial
In this study our Research Hospital San Donato Policlinic ask your partipation with the aim to evaluate the risk of cardiovascular complication (i.e. stroke, myocardial infarction) in patients with inflammatory bowel disease. Multiple parameters (therapy, disease activity, life style) and investigations (DNA, stool, lab tests) will be evaluate with the support of artificial intelligence methodologies to better define the cardiovascular risk.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Consecutive patients attending Gastroenterology and Cardiology Departments at IRCCS San Donato Policlinic
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
300 Participants
are grouped into 1 trial groupGroup A: Inflammatory Bowel Disease
Trial outcomes
Primary outcomes
1
Major cardiovascular events
Stroke, myocardial infarction, atrial fibrillation, ischemic heart disease, cardiovascular death, arterial embolism
Time frame
2 yearsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
IRCCS Policlinico S. Donato
Lead sponsor
IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: